Everest Medicines Announces NMPA Full Approval of...
Category : Approval/Launch 8 May 2025Everest Medicines a biopharmaceutical company focused on the discovery, clinical development, manufa...
Everest Medicines a biopharmaceutical company focused on the discovery, clinical development, manufa...
Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Applic...
Atzumi™ (dihydroergotamine(DHE)) nasal powder is the first and only DHE nasal powder for the a...
BridgeBio Pharma, Inc., a new type of biopharmaceutical company focused on genetic diseases, announc...
AbbVie announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), 15 mg...